Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction

Abstract DNA damage activates cell cycle checkpoint proteins ATR and CHK1 to arrest cell cycle progression, providing time for repair and recovery. Consequently, inhibitors of ATR (ATRi) and CHK1 (CHK1i) enhance damage-induced cell death. Intriguingly, both CHK1i and ATRi alone elicit cytotoxicity i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jennifer P. Ditano, Katelyn L. Donahue, Laura J. Tafe, Charlotte F. McCleery, Alan Eastman
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/5351eae2b961433688e264c109fd09cc
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5351eae2b961433688e264c109fd09cc
record_format dspace
spelling oai:doaj.org-article:5351eae2b961433688e264c109fd09cc2021-12-02T13:26:25ZSensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction10.1038/s41598-021-86490-x2045-2322https://doaj.org/article/5351eae2b961433688e264c109fd09cc2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-86490-xhttps://doaj.org/toc/2045-2322Abstract DNA damage activates cell cycle checkpoint proteins ATR and CHK1 to arrest cell cycle progression, providing time for repair and recovery. Consequently, inhibitors of ATR (ATRi) and CHK1 (CHK1i) enhance damage-induced cell death. Intriguingly, both CHK1i and ATRi alone elicit cytotoxicity in some cell lines. Sensitivity has been attributed to endogenous replications stress, but many more cell lines are sensitive to ATRi than CHK1i. Endogenous activation of the DNA damage response also did not correlate with drug sensitivity. Sensitivity correlated with the appearance of γH2AX, a marker of DNA damage, but without phosphorylation of mitotic markers, contradicting suggestions that the damage is due to premature mitosis. Sensitivity to ATRi has been associated with ATM mutations, but dysfunction in ATM signaling did not correlate with sensitivity. CHK1i and ATRi circumvent replication stress by reactivating stalled replicons, a process requiring a low threshold activity of CDK2. In contrast, γH2AX induced by single agent ATRi and CHK1i requires a high threshold activity CDK2. Hence, phosphorylation of different CDK2 substrates is required for cytotoxicity induced by replication stress plus ATRi/CHK1i as compared to their single agent activity. In summary, sensitivity to ATRi and CHK1i as single agents is elicited by premature hyper-activation of CDK2.Jennifer P. DitanoKatelyn L. DonahueLaura J. TafeCharlotte F. McCleeryAlan EastmanNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jennifer P. Ditano
Katelyn L. Donahue
Laura J. Tafe
Charlotte F. McCleery
Alan Eastman
Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
description Abstract DNA damage activates cell cycle checkpoint proteins ATR and CHK1 to arrest cell cycle progression, providing time for repair and recovery. Consequently, inhibitors of ATR (ATRi) and CHK1 (CHK1i) enhance damage-induced cell death. Intriguingly, both CHK1i and ATRi alone elicit cytotoxicity in some cell lines. Sensitivity has been attributed to endogenous replications stress, but many more cell lines are sensitive to ATRi than CHK1i. Endogenous activation of the DNA damage response also did not correlate with drug sensitivity. Sensitivity correlated with the appearance of γH2AX, a marker of DNA damage, but without phosphorylation of mitotic markers, contradicting suggestions that the damage is due to premature mitosis. Sensitivity to ATRi has been associated with ATM mutations, but dysfunction in ATM signaling did not correlate with sensitivity. CHK1i and ATRi circumvent replication stress by reactivating stalled replicons, a process requiring a low threshold activity of CDK2. In contrast, γH2AX induced by single agent ATRi and CHK1i requires a high threshold activity CDK2. Hence, phosphorylation of different CDK2 substrates is required for cytotoxicity induced by replication stress plus ATRi/CHK1i as compared to their single agent activity. In summary, sensitivity to ATRi and CHK1i as single agents is elicited by premature hyper-activation of CDK2.
format article
author Jennifer P. Ditano
Katelyn L. Donahue
Laura J. Tafe
Charlotte F. McCleery
Alan Eastman
author_facet Jennifer P. Ditano
Katelyn L. Donahue
Laura J. Tafe
Charlotte F. McCleery
Alan Eastman
author_sort Jennifer P. Ditano
title Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
title_short Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
title_full Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
title_fullStr Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
title_full_unstemmed Sensitivity of cells to ATR and CHK1 inhibitors requires hyperactivation of CDK2 rather than endogenous replication stress or ATM dysfunction
title_sort sensitivity of cells to atr and chk1 inhibitors requires hyperactivation of cdk2 rather than endogenous replication stress or atm dysfunction
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/5351eae2b961433688e264c109fd09cc
work_keys_str_mv AT jenniferpditano sensitivityofcellstoatrandchk1inhibitorsrequireshyperactivationofcdk2ratherthanendogenousreplicationstressoratmdysfunction
AT katelynldonahue sensitivityofcellstoatrandchk1inhibitorsrequireshyperactivationofcdk2ratherthanendogenousreplicationstressoratmdysfunction
AT laurajtafe sensitivityofcellstoatrandchk1inhibitorsrequireshyperactivationofcdk2ratherthanendogenousreplicationstressoratmdysfunction
AT charlottefmccleery sensitivityofcellstoatrandchk1inhibitorsrequireshyperactivationofcdk2ratherthanendogenousreplicationstressoratmdysfunction
AT alaneastman sensitivityofcellstoatrandchk1inhibitorsrequireshyperactivationofcdk2ratherthanendogenousreplicationstressoratmdysfunction
_version_ 1718393029181571072